Please login to the form below

Not currently logged in
Email:
Password:

Dr Catherine Strader joins Acorda Therapeutics’ board

She brings experience from Merck & Co and Synergy Partners R&D Solutions

Acorda Therapeutics has expanded its board of directors with the addition of Dr Catherine Strader.

Dr Strader is currently a founding partner at Synergy Partners R&D Solutions, and prior to co-founding the drug discovery and development network in 2014 was vice president and discovery site head at Merck & Co's New Jersey hub.

She also brings executive leadership experience from Schering-Plough, where she served as executive vice president of discovery research and chief scientific officer between 2002 and 2007.

Dr Ron Cohen, Acorda's president and chief executive officer, said: “Catherine brings decades of experience as both a drug developer and biopharmaceutical business executive with an outstanding track record of achievement.

“I expect her to add significant value to the board and the company as we continue to develop our pipeline and grow our business.”

23rd February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...

Infographics